Brief: Oxigene CFO Barbara Riching resigns
04/06/2015 11:04
June 4 (Reuters) - OXiGENE Inc OXGN.O : * On June 3, 2015, barbara riching resigned from her position as chief financial officer of Oxigene, inc.,effective immediately * Source text for Eikon ID:nEOL2Hl48f * Further company coverage OXGN.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Oncotelic Therapeutics
See all newsBrief: Oncotelic Therapeutics Emerging As Leader With New Independent JV Valuation
Brief: Oncotelic Therapeutics - JV Is Preparing For A Potential Initial Public Offering On The Hong Kong Stock Exchange In Late 2026
Brief: Oncotelic Therapeutics To Sell Its Necroptosis Cancer Therapy Assets To Mosaic Immunoengineering
Brief: Oncotelic Announces Initiation Of Clinical Study In Non-Small Lung Cell Cancer
Brief: Oncotelic Initiates Clinical Trials Evaluating Ot-101 Against Pediatric Gliomas